Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 2,856,782 | 2,965,160 | +108,378 | $277.82M | $555.32M | 14.20% | +$277.49M |
| Kymera Therapeutics, Inc.(KYMR) | 5,502,710 | 3,872,052 | -1,630,658 | $458.32M | $444.01M | 11.35% | -$14.31M |
| Xoma Royalty Corporation | 2,590,303 | 7,593,303 | +5,003,000 | $81.26M | $322.72M | 8.25% | +$241.46M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 16,001,284 | 16,001,284 | 0 | $298.26M | $311.54M | 7.97% | +$13.28M |
| GH Research PLC(GHRS) | 8,650,158 | 8,650,158 | 0 | $121.62M | $232.52M | 5.95% | +$110.90M |
| Structure Therapeutics IncADS | 3,459,358 | 3,366,823 | -92,535 | $166.74M | $180.70M | 4.62% | +$13.96M |
| Nektar Therapeutics(NKTR) | 2,559,595 | 2,391,075 | -168,520 | $184.16M | $166.92M | 4.27% | -$17.24M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,584,727 | 1,056,027 | -528,700 | $146.40M | $123.63M | 3.16% | -$22.77M |
| Xencor, Inc.(XNCR) | 7,133,720 | 7,133,720 | 0 | $86.03M | $114.85M | 2.94% | +$28.82M |
| Alkermes plcSHS(ALKS) | 2,000,000 | 2,154,704 | +154,704 | $70.72M | $112.90M | 2.89% | +$42.18M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,460,886 | 4,460,886 | 0 | $73.38M | $107.95M | 2.76% | +$34.57M |
| Cullinan Therapeutics, Inc.(CGEM) | 5,750,683 | 5,750,683 | 0 | $81.72M | $104.72M | 2.68% | +$23.00M |
| Palvella Therapeutics, Inc.(PVLA) | 960,989 | 672,789 | -288,200 | $119.79M | $102.82M | 2.63% | -$16.97M |
| Zymeworks Inc.(ZYME) | 3,734,142 | 3,649,142 | -85,000 | $93.50M | $95.39M | 2.44% | +$1.89M |
| Kura Oncology, Inc.(KURA) | 8,445,769 | 8,445,769 | 0 | $68.66M | $92.65M | 2.37% | +$23.99M |
| Disc Medicine, Inc.(IRON) | 1,272,312 | 1,153,612 | -118,700 | $81.35M | $84.38M | 2.16% | +$3.02M |
| Stoke Therapeutics, Inc.(STOK) | 2,547,557 | 2,547,557 | 0 | $82.95M | $83.36M | 2.13% | +$407.6K |
| Olema Pharmaceuticals, Inc.(OLMA) | 5,295,893 | 5,295,893 | 0 | $78.96M | $66.25M | 1.69% | -$12.71M |
| Annexon, Inc.(ANNX) | 8,698,173 | 8,698,173 | 0 | $48.19M | $49.67M | 1.27% | +$1.48M |
| Crescent Biopharma, Inc.(CBIO) | 2,748,763 | 2,748,763 | 0 | $50.49M | $49.48M | 1.27% | -$1.02M |
| AC Immune SASHS(ACIU) | 19,822,436 | 19,822,436 | 0 | $54.51M | $47.18M | 1.21% | -$7.33M |
| Tyra Biosciences, Inc.(TYRA) | 1,976,196 | 1,476,196 | -500,000 | $75.69M | $47.15M | 1.21% | -$28.54M |
| Sutro Biopharma, Inc.(STRO) | 1,251,788 | 1,251,788 | 0 | $31.18M | $41.56M | 1.06% | +$10.38M |
| Immunocore Holdings plcADS(IMCR) | 1,294,463 | 1,294,463 | 0 | $39.03M | $41.10M | 1.05% | +$2.07M |
| Avalo Therapeutics, Inc.(AVTX) | 1,632,845 | 2,075,545 | +442,700 | $24.38M | $38.36M | 0.98% | +$13.98M |
| 4d Molecular Therapeutics In | 2,879,289 | 2,879,289 | 0 | $26.81M | $38.29M | 0.98% | +$11.49M |
| Q32 Bio Inc.(QTTB) | 0 | 2,350,000 | +2,350,000 | $0 | $29.94M | 0.77% | +$29.94M |
| Anteris Technologies Global Corp.(AVR) | 3,000,000 | 3,000,000 | 0 | $16.65M | $29.55M | 0.76% | +$12.90M |
| Foghorn Therapeutics Inc.(FHTX) | 5,842,000 | 5,842,000 | 0 | $27.92M | $28.51M | 0.73% | +$584.2K |
| Absci Corporation | 0 | 2,361,674 | +2,361,674 | $0 | $27.37M | 0.70% | +$27.37M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 6,293,282 | 6,293,282 | 0 | $19.38M | $24.80M | 0.63% | +$5.41M |
| Invivyd, Inc.(IVVD) | 19,525,000 | 28,165,000 | +8,640,000 | $25.38M | $24.57M | 0.63% | -$811.4K |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 0 | 2,500,000 | +2,500,000 | $0 | $19.32M | 0.49% | +$19.32M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 1,978,972 | 3,235,778 | +1,256,806 | $8.19M | $14.76M | 0.38% | +$6.56M |
| Immunic, Inc.(IMUX) | 0 | 765,295 | +765,295 | $0 | $11.76M | 0.30% | +$11.76M |
| X4 Pharmaceuticals, Inc.(XFOR) | 2,233,742 | 2,233,742 | 0 | $9.23M | $10.43M | 0.27% | +$1.21M |
| ImageneBio, Inc.(IMA) | 1,110,002 | 1,110,002 | 0 | $5.55M | $6.55M | 0.17% | +$999.0K |
| TScan Therapeutics, Inc.(TCRX) | 5,564,290 | 5,564,290 | 0 | $5.62M | $5.45M | 0.14% | -$166.4K |
| Research Alliance Corp IiiCL A | 0 | 500,000 | +500,000 | $0 | $5.35M | 0.14% | +$5.35M |
| Molecular Partners AGADS(MOLN) | 1,353,968 | 1,353,968 | 0 | $5.36M | $5.15M | 0.13% | -$216.6K |
| Tenax Therapeutics, Inc.(TENX) | 339,549 | 339,549 | 0 | $5.43M | $4.94M | 0.13% | -$489.0K |
| Entera Bio Ltd.SHS(ENTX) | 0 | 2,425,000 | +2,425,000 | $0 | $4.29M | 0.11% | +$4.29M |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $3.81M | $2.59M | 0.07% | -$1.21M |
| Engene TherapeuticsW EXP 10 31 202 | 0 | 945,402 | +945,402 | $0 | $274.1K | 0.01% | +$274.1K |
| Compass Therapeutics, Inc.(CMPX) | 7,764,842 | 0 | -7,764,842 | $41.08M | $0 | — | -$41.08M |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 945,402 | 0 | -945,402 | $2.49M | $0 | — | -$2.49M |
| Immunic, Inc.(IMUX) | 7,652,972 | 0 | -7,652,972 | $8.49M | $0 | — | -$8.49M |
| Septerna, Inc.(SEPN) | 1,353,249 | 0 | -1,353,249 | $32.52M | $0 | — | -$32.52M |